BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

445 related articles for article (PubMed ID: 15851637)

  • 1. Population-based drug-induced agranulocytosis.
    Ibáñez L; Vidal X; Ballarín E; Laporte JR
    Arch Intern Med; 2005 Apr; 165(8):869-74. PubMed ID: 15851637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prospective study of the incidence of agranulocytosis and aplastic anemia associated with the oral use of metamizole sodium in Poland.
    Maj S; Centkowski P
    Med Sci Monit; 2004 Sep; 10(9):PI93-5. PubMed ID: 15328493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Agranulocytosis and other blood dyscrasias associated with dipyrone (metamizole).
    Hedenmalm K; Spigset O
    Eur J Clin Pharmacol; 2002 Jul; 58(4):265-74. PubMed ID: 12136373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug associated cutaneous vasculitis in adults in northwestern Spain.
    García-Porrúa C; González-Gay MA; López-Lázaro L
    J Rheumatol; 1999 Sep; 26(9):1942-4. PubMed ID: 10493674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rare but serious risks associated with non-narcotic analgesics: clinical experience.
    Kewitz H
    Med Toxicol; 1986; 1 Suppl 1():86-92. PubMed ID: 3821433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Risk of drug-induced agranulocytosis: an approximation to risk analysis arising from spontaneous notification of agranulocytosis cases among patients treated with calcium dobesilate].
    Zapater Hernández P; Horga de la Parte JF; García AG
    An Med Interna; 2002 Jun; 19(6):275-82. PubMed ID: 12152385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-infective drug use in relation to the risk of agranulocytosis and aplastic anemia. A report from the International Agranulocytosis and Aplastic Anemia Study.
    Arch Intern Med; 1989 May; 149(5):1036-40. PubMed ID: 2785785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neutropenia and agranulocytosis in England and Wales: incidence and risk factors.
    van Staa TP; Boulton F; Cooper C; Hagenbeek A; Inskip H; Leufkens HG
    Am J Hematol; 2003 Apr; 72(4):248-54. PubMed ID: 12666135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiology of aplastic anemia: a prospective multicenter study.
    Montané E; Ibáñez L; Vidal X; Ballarín E; Puig R; García N; Laporte JR;
    Haematologica; 2008 Apr; 93(4):518-23. PubMed ID: 18322256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utilization pattern of metamizole in northern Sweden and risk estimates of agranulocytosis.
    Bäckström M; Hägg S; Mjörndal T; Dahlqvist R
    Pharmacoepidemiol Drug Saf; 2002; 11(3):239-45. PubMed ID: 12051124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retrospective prevalence and incidence of drug-induced agranulocytosis in the city of São Paulo-Brasil.
    Hamerschlak N; Montezuma MP; Bacal N; Szterling LN; Rosenfeld LG; Guerra CC
    Rev Paul Med; 1993; 111(1):294-8. PubMed ID: 8235248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Idiosyncratic drug-induced agranulocytosis or acute neutropenia.
    Andrès E; Maloisel F
    Curr Opin Hematol; 2008 Jan; 15(1):15-21. PubMed ID: 18043241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clozapine-induced agranulocytosis. Incidence and risk factors in the United States.
    Alvir JM; Lieberman JA; Safferman AZ; Schwimmer JL; Schaaf JA
    N Engl J Med; 1993 Jul; 329(3):162-7. PubMed ID: 8515788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Incidence and probable etiology of toxic agranulocytosis in a definite population in the province of Buenos Aires (1963-1976)].
    Larregina A; Aggio MC; Alvarez RV
    Medicina (B Aires); 1994; 54(1):13-6. PubMed ID: 7990680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug-induced agranulocytosis: experience in two university hospitals.
    Lekhakula A; Swasdikul D
    J Med Assoc Thai; 1991 Mar; 74(3):121-30. PubMed ID: 1861127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of antisecretory drugs and nitrates on the risk of ulcer bleeding associated with nonsteroidal anti-inflammatory drugs, antiplatelet agents, and anticoagulants.
    Lanas A; García-Rodríguez LA; Arroyo MT; Bujanda L; Gomollón F; Forné M; Aleman S; Nicolas D; Feu F; González-Pérez A; Borda A; Castro M; Poveda MJ; Arenas J;
    Am J Gastroenterol; 2007 Mar; 102(3):507-15. PubMed ID: 17338735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risks of agranulocytosis and aplastic anemia. A first report of their relation to drug use with special reference to analgesics. The International Agranulocytosis and Aplastic Anemia Study.
    JAMA; 1986 Oct; 256(13):1749-57. PubMed ID: 3747087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of non-Hodgkin lymphoma and use of non-steroidal anti-inflammatory drugs.
    Zhang Y; Coogan PF; Palmer JR; Strom BL; Rosenberg L
    Cancer Detect Prev; 2006; 30(1):99-101. PubMed ID: 16495019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Descriptive epidemiology of agranulocytosis.
    Strom BL; Carson JL; Schinnar R; Snyder ES; Shaw M
    Arch Intern Med; 1992 Jul; 152(7):1475-80. PubMed ID: 1627027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug-induced agranulocytosis. A survey of twenty-three episodes.
    Mintz U; Shaklai M; Pinkhas J; de Vries A
    Med Interne; 1975; 13(3):205-8. PubMed ID: 52883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.